Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

RETRIeVE: ReversE TranscRiptase Inhibitor hiV Practice

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Dr. Mark Bloch, Holdsworth House Medical Practice
ClinicalTrials.gov Identifier:
NCT01154556
First received: June 30, 2010
Last updated: September 8, 2013
Last verified: September 2013

June 30, 2010
September 8, 2013
June 2010
September 2011   (final data collection date for primary outcome measure)
resistance profiling and subsequent prescription patterns of patients on NNRTIs [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Not Provided
Complete list of historical versions of study NCT01154556 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
RETRIeVE: ReversE TranscRiptase Inhibitor hiV Practice
Non-nucleoside Reverse Transcriptase Inhibitor Failure in a High HIV Caseload Australian Primary Care Practice

An observational retrospective study of NNRTI experienced patients who have virologically failed. The study aims to assess resistance profiling and subsequent prescription patterns of patients on NNRTIs

This is a cross-sectional study involving retrospective review of HIV-1 positive patient records who began treatment with a non-nucleoside reverse transcriptase inhibitor (NNRTI) and subsequently failed. Patients who have virologically failed previous NNRTI treatment, or have resistance to 1 drug in the NNRTI class are examined further. Such patients will have attended the clinic every 3-6 months for routine medical care. The data source for variables collected is the patient's electronic medical records. This database is located at Holdsworth House Medical Practice (HHMP), Sydney.

Observational
Time Perspective: Retrospective
Not Provided
Not Provided
Probability Sample

Demographic information will be collected from patient medical records for all patients that have used previously, or are currently using an NNRTI as part of HIV treatment therapy.

HIV Positive
Not Provided
HIV1 positive, NNRTI exposure and failure
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
1000
Not Provided
September 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  1. Documented HIV infection
  2. Attended Holdsworth House Medical Practice 1999-2009.
  3. Chosen ART regime includes an NNRTI

Exclusion Criteria: N/A

Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
Australia
 
NCT01154556
RETRIeVE
Not Provided
Dr. Mark Bloch, Holdsworth House Medical Practice
Holdsworth House Medical Practice
Not Provided
Not Provided
Holdsworth House Medical Practice
September 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP